ENDRA Life Sciences- Warrants (12/05/2022) Total Revenue

ENDRA Life Sciences- Warrants (12/05/2022) (NDRAW) currently reports a total revenue of $0 as of June 2026. In the prior-year period, the figure was $0. That is below the Technology sector average of $38T. Use the charts on this page to explore ENDRA Life Sciences- Warrants (12/05/2022)'s total revenue history and peer comparisons.

ENDRA Life Sciences- Warrants (12/05/2022)'s total revenue changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ENDRA Life Sciences- Warrants (12/05/2022)'s total revenue of $0 is lower than the Technology sector average of $38T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

ENDRA Life Sciences- Warrants (12/05/2022) reported $0 in total revenue as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $38T. From there, open related valuation or income-statement pages for ENDRA Life Sciences- Warrants (12/05/2022), and consider following NDRAW for alerts when major investors trade the stock.